Published in PLoS One on May 21, 2013
Genetic variability of microRNA regulome in human. Mol Genet Genomic Med (2014) 0.87
Prognostic role of common microRNA polymorphisms in cancers: evidence from a meta-analysis. PLoS One (2014) 0.87
MicroRNA-binding site polymorphisms in hematological malignancies. J Hematol Oncol (2014) 0.83
Significance of microRNA-related variants in susceptibility to recurrence of oropharyngeal cancer patients after definitive radiotherapy. Oncotarget (2016) 0.77
MiRNAs and miRNA Polymorphisms Modify Drug Response. Int J Environ Res Public Health (2016) 0.75
Association between Polymorphism of Exportin-5 and Susceptibility to Lead Poisoning in a Chinese Population. Int J Environ Res Public Health (2016) 0.75
Association of Polymorphic Variants of miRNA Processing Genes with Larynx Cancer Risk in a Polish Population. Biomed Res Int (2015) 0.75
Association of polymorphisms at the microRNA binding site of the caprine KITLG 3'-UTR with litter size. Sci Rep (2016) 0.75
MicroRNAs: genomics, biogenesis, mechanism, and function. Cell (2004) 198.59
MicroRNAs: target recognition and regulatory functions. Cell (2009) 92.17
Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep (1966) 48.83
Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol (2009) 19.99
Nuclear export of microRNA precursors. Science (2003) 16.59
TRBP recruits the Dicer complex to Ago2 for microRNA processing and gene silencing. Nature (2005) 13.44
Non-coding RNAs in human disease. Nat Rev Genet (2011) 11.40
Adjusting for multiple testing--when and how? J Clin Epidemiol (2001) 8.85
A prognostic score for advanced Hodgkin's disease. International Prognostic Factors Project on Advanced Hodgkin's Disease. N Engl J Med (1998) 8.24
Natural selection has driven population differentiation in modern humans. Nat Genet (2008) 7.48
Genetic variation in microRNA networks: the implications for cancer research. Nat Rev Cancer (2010) 7.39
Chemotherapy of advanced Hodgkin's disease with MOPP, ABVD, or MOPP alternating with ABVD. N Engl J Med (1992) 5.42
Retracted A TARBP2 mutation in human cancer impairs microRNA processing and DICER1 function. Nat Genet (2009) 3.88
Genetic variants of miRNA sequences and non-small cell lung cancer survival. J Clin Invest (2008) 3.53
The biology of Hodgkin's lymphoma. Nat Rev Cancer (2008) 3.31
Up-regulation of dicer, a component of the MicroRNA machinery, in prostate adenocarcinoma. Am J Pathol (2006) 3.30
A miR-24 microRNA binding-site polymorphism in dihydrofolate reductase gene leads to methotrexate resistance. Proc Natl Acad Sci U S A (2007) 3.15
Randomized comparison of ABVD and MOPP/ABV hybrid for the treatment of advanced Hodgkin's disease: report of an intergroup trial. J Clin Oncol (2003) 3.00
Reduced treatment intensity in patients with early-stage Hodgkin's lymphoma. N Engl J Med (2010) 2.97
A genetic defect in exportin-5 traps precursor microRNAs in the nucleus of cancer cells. Cancer Cell (2010) 2.78
Overexpression of Dicer in precursor lesions of lung adenocarcinoma. Cancer Res (2007) 2.65
Aberrant allele frequencies of the SNPs located in microRNA target sites are potentially associated with human cancers. Nucleic Acids Res (2007) 2.48
Evaluation of genetic variants in microRNA-related genes and risk of bladder cancer. Cancer Res (2008) 2.37
Mechanisms of microRNA deregulation in human cancer. Cell Cycle (2008) 2.30
A let-7 microRNA-binding site polymorphism in the KRAS 3' UTR is associated with reduced survival in oral cancers. Carcinogenesis (2009) 2.28
Bleomycin-induced pneumonitis. Chest (2001) 2.13
Early-stage Hodgkin's lymphoma. N Engl J Med (2010) 2.06
MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine. Pharmacogenomics (2009) 1.88
MiRSNPs or MiR-polymorphisms, new players in microRNA mediated regulation of the cell: Introducing microRNA pharmacogenomics. Cell Cycle (2008) 1.74
MicroRNA expression profiling in classic Hodgkin lymphoma. Blood (2007) 1.64
MicroRNA-mediated down-regulation of PRDM1/Blimp-1 in Hodgkin/Reed-Sternberg cells: a potential pathogenetic lesion in Hodgkin lymphomas. Am J Pathol (2008) 1.57
Twenty years of MOPP therapy for Hodgkin's disease. J Clin Oncol (1986) 1.55
Genetic variations of microRNAs in human cancer and their effects on the expression of miRNAs. Carcinogenesis (2008) 1.51
Regulation of JAK2 by miR-135a: prognostic impact in classic Hodgkin lymphoma. Blood (2009) 1.45
Hodgkin lymphoma cell lines are characterized by a specific miRNA expression profile. Neoplasia (2009) 1.44
Role of primary miRNA polymorphic variants in metastatic colon cancer patients treated with 5-fluorouracil and irinotecan. Pharmacogenomics J (2010) 1.33
Genetic variation in MicroRNA genes and risk of oral premalignant lesions. Mol Carcinog (2010) 1.32
A dual role for KRT81: a miR-SNP associated with recurrence in non-small-cell lung cancer and a novel marker of squamous cell lung carcinoma. PLoS One (2011) 1.28
Competition for XPO5 binding between Dicer mRNA, pre-miRNA and viral RNA regulates human Dicer levels. Nat Struct Mol Biol (2011) 1.16
Pharmacogenomics of microRNA: a miRSNP towards individualized therapy. Pharmacogenomics (2007) 1.08
Impact of MiRSNPs on survival and progression in patients with multiple myeloma undergoing autologous stem cell transplantation. Clin Cancer Res (2012) 1.05
GWAPower: a statistical power calculation software for genome-wide association studies with quantitative traits. BMC Genet (2011) 1.04
Neurologic complications of cancer chemotherapy. Semin Oncol (2006) 0.98
Biologic features of Hodgkin lymphoma and the development of biologic prognostic factors in Hodgkin lymphoma: tumor and microenvironment. Leuk Lymphoma (2008) 0.97
Effect of IL-6 promoter polymorphism on incidence and outcome in Hodgkin's lymphoma. Br J Haematol (2005) 0.94
Personalized medicine: a reality within this decade. J Cardiovasc Transl Res (2008) 0.93
Serious pulmonary toxicity in patients with Hodgkin's lymphoma with SGN-30, gemcitabine, vinorelbine, and liposomal doxorubicin is associated with an FcγRIIIa-158 V/F polymorphism. Ann Oncol (2010) 0.90
Hodgkin disease: prognostic factors and treatment strategies. Curr Opin Oncol (2000) 0.86
Comparison of miRNA profiles of microdissected Hodgkin/Reed-Sternberg cells and Hodgkin cell lines versus CD77+ B-cells reveals a distinct subset of differentially expressed miRNAs. Br J Haematol (2009) 0.85
Pharmacogenetic study in Hodgkin lymphomas reveals the impact of UGT1A1 polymorphisms on patient prognosis. Blood (2008) 0.83
Optimal therapy of advanced Hodgkin lymphoma. Hematology Am Soc Hematol Educ Program (2011) 0.81
Hodgkin lymphoma risk: role of genetic polymorphisms and gene-gene interactions in DNA repair pathways. Mol Carcinog (2011) 0.79
Treatment for relapse in stage I/II Hodgkin's lymphoma after initial single-modality treatment. Clin Lymphoma Myeloma (2006) 0.79
Approach to Hodgkin's lymphoma in the new millennium. Hematol Oncol (2002) 0.77
German Hodgkin's Lymphoma Study Group trials: lessons from the past and current strategies. Clin Lymphoma Myeloma (2006) 0.76
Hodgkin's lymphoma: molecular targets and novel treatment strategies. Future Oncol (2006) 0.76
Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria. Blood (2007) 2.76
miR-34a as a prognostic marker of relapse in surgically resected non-small-cell lung cancer. Carcinogenesis (2009) 2.41
High numbers of tumor-infiltrating FOXP3-positive regulatory T cells are associated with improved overall survival in follicular lymphoma. Blood (2006) 2.40
Clonally related follicular lymphomas and histiocytic/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone. Blood (2008) 2.15
Role of miR-200 family members in survival of colorectal cancer patients treated with fluoropyrimidines. J Surg Oncol (2014) 2.10
Early detection of Toxoplasma infection by molecular monitoring of Toxoplasma gondii in peripheral blood samples after allogeneic stem cell transplantation. Clin Infect Dis (2004) 1.98
Hematopoiesis-related microRNA expression in myelodysplastic syndromes. Leuk Lymphoma (2009) 1.88
Overlapping expression of microRNAs in human embryonic colon and colorectal cancer. Cell Res (2008) 1.72
Dasty3, a WEB framework for DAS. Bioinformatics (2011) 1.67
Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma. Blood (2014) 1.66
MicroRNA expression profiling in classic Hodgkin lymphoma. Blood (2007) 1.64
Anatomic aspects of the atrioventricular junction influencing radiofrequency Cox maze IV procedures. J Thorac Cardiovasc Surg (2008) 1.61
Forward genetic screen for malignant peripheral nerve sheath tumor formation identifies new genes and pathways driving tumorigenesis. Nat Genet (2013) 1.60
Pint lincRNA connects the p53 pathway with epigenetic silencing by the Polycomb repressive complex 2. Genome Biol (2013) 1.47
Agomelatine, the first melatonergic antidepressant: discovery, characterization and development. Nat Rev Drug Discov (2010) 1.47
The incidence of veno-occlusive disease following allogeneic hematopoietic stem cell transplantation has diminished and the outcome improved over the last decade. Biol Blood Marrow Transplant (2011) 1.45
Regulation of JAK2 by miR-135a: prognostic impact in classic Hodgkin lymphoma. Blood (2009) 1.45
High numbers of tumor-infiltrating programmed cell death 1-positive regulatory lymphocytes are associated with improved overall survival in follicular lymphoma. J Clin Oncol (2009) 1.40
The Bloodgen Project of the European Union, 2003-2009. Transfus Med Hemother (2009) 1.36
Clinical patterns and outcomes of ischaemic colitis: results of the Working Group for the Study of Ischaemic Colitis in Spain (CIE study). Scand J Gastroenterol (2010) 1.33
Chronic restraint stress up-regulates GLT-1 mRNA and protein expression in the rat hippocampus: reversal by tianeptine. Proc Natl Acad Sci U S A (2004) 1.30
A dual role for KRT81: a miR-SNP associated with recurrence in non-small-cell lung cancer and a novel marker of squamous cell lung carcinoma. PLoS One (2011) 1.28
The BloodGen project: toward mass-scale comprehensive genotyping of blood donors in the European Union and beyond. Transfusion (2007) 1.24
The management of pregnancy in paroxysmal nocturnal haemoglobinuria on long term eculizumab. Br J Haematol (2010) 1.20
[Diagnosis and treatment of nocturnal paroxysmal hemoglobinuria]. Med Clin (Barc) (2010) 1.10
Efficacy and tolerability of hydroxyurea in the treatment of the hyperproliferative manifestations of myelofibrosis: results in 40 patients. Ann Hematol (2010) 1.10
Sensitivity and specificity of nested and real-time PCR for the detection of Pneumocystis jiroveci in clinical specimens. Diagn Microbiol Infect Dis (2006) 1.09
Impact of MiRSNPs on survival and progression in patients with multiple myeloma undergoing autologous stem cell transplantation. Clin Cancer Res (2012) 1.05
Prognostic implications of miR-16 expression levels in resected non-small-cell lung cancer. J Surg Oncol (2010) 1.05
Use of colour Doppler imaging in ocular blood flow research. Acta Ophthalmol (2011) 1.04
Low adherence to colonoscopy in the screening of first-degree relatives of patients with colorectal cancer. Gut (2007) 1.04
Lestaurtinib inhibition of the Jak/STAT signaling pathway in hodgkin lymphoma inhibits proliferation and induces apoptosis. PLoS One (2011) 1.03
NPM-ALK-dependent expression of the transcription factor CCAAT/enhancer binding protein beta in ALK-positive anaplastic large cell lymphoma. Blood (2006) 1.03
Single-nucleotide polymorphisms in base excision repair, nucleotide excision repair, and double strand break genes as markers for response to radiotherapy in patients with Stage I to II head-and-neck cancer. Int J Radiat Oncol Biol Phys (2006) 1.02
Low miR-145 and high miR-367 are associated with unfavourable prognosis in resected nonsmall cell lung cancer. Eur Respir J (2012) 1.01
Cutaneous gamma/delta T-cell lymphoma: a histopathologic mimicker of lupus erythematosus profundus (lupus panniculitis). J Am Acad Dermatol (2007) 1.00
Factors associated with collagen deposition in lymphoid tissue in long-term treated HIV-infected patients. AIDS (2010) 1.00
Mannan-binding lectin pathway deficiencies and invasive fungal infections following allogeneic stem cell transplantation. Exp Hematol (2006) 0.99
Single nucleotide polymorphisms in nucleotide excision repair genes XPA, XPD, XPG and ERCC1 in advanced colorectal cancer patients treated with first-line oxaliplatin/fluoropyrimidine. Oncology (2008) 0.98
Correlation between genetic polymorphisms of the hOCT1 and MDR1 genes and the response to imatinib in patients newly diagnosed with chronic-phase chronic myeloid leukemia. Leuk Res (2010) 0.96
Redistribution of FOXP3-positive regulatory T cells from lymphoid tissues to peripheral blood in HIV-infected patients. J Acquir Immune Defic Syndr (2007) 0.95
Nonhepatosplenic γδ T-cell lymphomas represent a spectrum of aggressive cytotoxic T-cell lymphomas with a mainly extranodal presentation. Am J Surg Pathol (2011) 0.95
myKaryoView: a light-weight client for visualization of genomic data. PLoS One (2011) 0.94
Differential effects of predator stress and the antidepressant tianeptine on physiological plasticity in the hippocampus and basolateral amygdala. Stress (2006) 0.94
Case-control comparison of at-home to total hospital care for autologous stem-cell transplantation for hematologic malignancies. J Clin Oncol (2006) 0.93
Spleen rupture in a case of untreated Plasmodium vivax infection. PLoS Negl Trop Dis (2012) 0.93
Herpes simplex and Epstein-Barr virus lymphadenitis in a patient with chronic lymphocytic leukemia treated with fludarabine. Eur J Haematol (2006) 0.92
Inflammatory markers are associated with outcome in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization. Ann Surg Oncol (2012) 0.92
Molecular characterization of familial hypercholesterolemia in Spain. Atherosclerosis (2011) 0.90
The expression of the endoplasmic reticulum stress sensor BiP/GRP78 predicts response to chemotherapy and determines the efficacy of proteasome inhibitors in diffuse large b-cell lymphoma. Am J Pathol (2011) 0.89
Effects of milk enriched with omega-3 fatty acid, oleic acid and folic acid in patients with metabolic syndrome. Clin Nutr (2006) 0.89
Environmental tobacco smoke exposure in children: parental perception of smokiness at home and other factors associated with urinary cotinine in preschool children. J Expo Anal Environ Epidemiol (2004) 0.89
Capnocytophaga canimorsus infection with fulminant sepsis in an asplenic patient: diagnosis by review of peripheral blood smear. Am J Hematol (2008) 0.88
Prognosis of patients with diffuse large B cell lymphoma not reaching complete response or relapsing after frontline chemotherapy or immunochemotherapy. Ann Hematol (2014) 0.88
Reduced-intensity conditioning regimen preserves thymic function in the early period after hematopoietic stem cell transplantation. Exp Hematol (2005) 0.87
Effect of NOD2/CARD15 variants in T-cell depleted allogeneic stem cell transplantation. Haematologica (2006) 0.87
Primary cutaneous small/medium CD4+ T-cell lymphomas: a heterogeneous group of tumors with different clinicopathologic features and outcome. J Clin Oncol (2008) 0.87
Lack of methylthioadenosine phosphorylase expression in mantle cell lymphoma is associated with shorter survival: implications for a potential targeted therapy. Clin Cancer Res (2006) 0.87
Is maternal smoking more determinant than paternal smoking on the respiratory symptoms of young children? Respir Med (2005) 0.86
Assessment of SOX11 expression in routine lymphoma tissue sections: characterization of new monoclonal antibodies for diagnosis of mantle cell lymphoma. Am J Surg Pathol (2014) 0.85
Achalasia and mycobacterium goodii pulmonary infection. Pediatr Infect Dis J (2011) 0.85
Impact on response and survival of DNA repair single nucleotide polymorphisms in relapsed or refractory multiple myeloma patients treated with thalidomide. Leuk Res (2011) 0.84
Weekly paclitaxel for platin-resistant stage IV head and neck cancer patients. Acta Otolaryngol (2009) 0.84
Common variants in NLRP2 and NLRP3 genes are strong prognostic factors for the outcome of HLA-identical sibling allogeneic stem cell transplantation. Blood (2008) 0.83
Lymphoid tissue collagen deposition in HIV-infected patients correlates with the imbalance between matrix metalloproteinases and their inhibitors. J Infect Dis (2011) 0.82
Usefulness of oral beclometasone dipropionate in the treatment of active ulcerative colitis in clinical practice: the RECLICU Study. J Crohns Colitis (2010) 0.82
Efficacy of lenalidomide in a patient with myelodysplastic syndrome with isolated del(5q) and JAK2V617F mutation. Leuk Res (2011) 0.82
Prevention of chemotherapy-induced left ventricular dysfunction with enalapril and carvedilol: rationale and design of the OVERCOME trial. J Card Fail (2011) 0.82
Pre-training administration of tianeptine, but not propranolol, protects hippocampus-dependent memory from being impaired by predator stress. Eur Neuropsychopharmacol (2007) 0.82
Kinetics of recovery of dendritic cell subsets after reduced-intensity conditioning allogeneic stem cell transplantation and clinical outcome. Haematologica (2007) 0.82
XIAP inhibitors induce differentiation and impair clonogenic capacity of acute myeloid leukemia stem cells. Oncotarget (2014) 0.82
The impact of intraocular pressure reduction on retrobulbar hemodynamic parameters in patients with open-angle glaucoma. Eur J Ophthalmol (2011) 0.81
Pervasive self-care solutions in telecardiology. Typical use cases from the EPI-MEDICS project. Stud Health Technol Inform (2003) 0.81
Spectrum of CBS mutations in 16 homocystinuric patients from the Iberian Peninsula: high prevalence of T191M and absence of I278T or G307S. Hum Mutat (2003) 0.81
Maslinic acid derivatives induce significant apoptosis in b16f10 murine melanoma cells. Eur J Med Chem (2011) 0.81
Ultrastructural and immunohistochemical analysis of intestinal myofibroblasts during the early organogenesis of the human small intestine. Anat Rec (Hoboken) (2011) 0.81
Solution- and solid-phase synthesis and anti-HIV activity of maslinic acid derivatives containing amino acids and peptides. Bioorg Med Chem (2008) 0.81
DRUG FOCUS: S 18986: A positive allosteric modulator of AMPA-type glutamate receptors pharmacological profile of a novel cognitive enhancer. CNS Neurosci Ther (2010) 0.80
Impact of global and gene-specific DNA methylation pattern in relapsed multiple myeloma patients treated with bortezomib. Leuk Res (2013) 0.80